In addition, in subcutaneous xenotransplants using the pancreas carcinoma cell line AsPC-1 (33), which expresses CCR9 on its surface, there was a significant difference on the weight of the tumors. This evidence concerns the gene CCR9 and exocrine pancreatic carcinoma.